Inventor

DAMBROVA MAIJA

LV9 patents

⚠️ This page may combine multiple inventors who share the name “DAMBROVA MAIJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KALVINS IVARS

3 patents

US8940793B2Jan 27, 2015

4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease

KALVINS IVARS3 citations52

US9278907B2Mar 8, 2016

Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

KALVINS IVARS0 citations45

US8791273B2Jul 29, 2014

4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity

KALVINS IVARS0 citations30

JSC GRINDEKS

2 patents

US9573882B2Feb 21, 2017

Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

JSC GRINDEKS0 citations44

US10351534B2Jul 16, 2019

Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

JSC GRINDEKS0 citations43

WAPHARM AB

1 patent

US6599943B1Jul 29, 2003

Use of hydroxyguanidines

WAPHARM AB12 citations62

LATVIAN INST ORGANIC SYNTHESIS

1 patent

US10105348B2Oct 23, 2018

Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures

LATVIAN INST ORGANIC SYNTHESIS0 citations37

JOINT STOCK COMPANY JSC “OLAINFARM”

1 patent

US9382203B2Jul 5, 2016

N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use

JOINT STOCK COMPANY JSC “OLAINFARM”0 citations36

VEINBERG GRIGORY

1 patent

US9102615B2Aug 11, 2015

N-Carbamoylmethy1-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use

VEINBERG GRIGORY0 citations36